ATRA
Price
$9.43
Change
+$0.08 (+0.86%)
Updated
Oct 22 closing price
Capitalization
94.66M
20 days until earnings call
Intraday BUY SELL Signals
INVA
Price
$21.06
Change
+$0.15 (+0.72%)
Updated
Oct 22 closing price
Capitalization
1.52B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATRA vs INVA

ATRA vs INVA Comparison Chart in %
View a ticker or compare two or three
VS
ATRA vs. INVA commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a StrongBuy and INVA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ATRA with price predictions
Oct 22, 2026

ATRA in upward trend: 10-day moving average moved above 50-day moving average on October 13, 2026

The 10-day moving average for ATRA crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 63 cases where ATRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ATRA as a result. In 74 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for ATRA just turned positive on October 21, 2026. Looking at past instances where ATRA's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.

ATRA moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRA advanced for three days, in 231 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

ATRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for ATRA entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.559) is normal, around the industry mean (2.973). P/E Ratio (-6.163) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (22.883) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ATRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for INVA with price predictions
Oct 22, 2026

INVA in upward trend: price rose above 50-day moving average on October 22, 2026

INVA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on INVA as a result. In 41 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.

The Moving Average Convergence Divergence (MACD) for INVA just turned positive on October 07, 2026. Looking at past instances where INVA's MACD turned positive, the stock continued to rise in 28 of 44 cases over the following month. The odds of a continued upward trend are 64%.

The 10-day moving average for INVA crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.

Following a +2.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVA advanced for three days, in 187 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

INVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 111 of 204 cases where INVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 55 cases where INVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. INVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.234) is normal, around the industry mean (2.973). P/E Ratio (4.089) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (3.173) is also within normal values, averaging (9.059). Dividend Yield (0.047) settles around the average of (128.121) among similar stocks. P/S Ratio (4.092) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
ATRA vs INVA: Fundamental Ratings
ATRA
INVA
OUTLOOK RATING
1..100
714
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10066
SMR RATING
1..100
10028
PRICE GROWTH RATING
1..100
4055
P/E GROWTH RATING
1..100
9796
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRA's Valuation (16) in the Biotechnology industry is significantly better than the same rating for INVA (84) in the Pharmaceuticals Other industry. This means that ATRA’s stock grew significantly faster than INVA’s over the last 12 months.

INVA's Profit vs Risk Rating (66) in the Pharmaceuticals Other industry is somewhat better than the same rating for ATRA (100) in the Biotechnology industry. This means that INVA’s stock grew somewhat faster than ATRA’s over the last 12 months.

INVA's SMR Rating (28) in the Pharmaceuticals Other industry is significantly better than the same rating for ATRA (100) in the Biotechnology industry. This means that INVA’s stock grew significantly faster than ATRA’s over the last 12 months.

ATRA's Price Growth Rating (40) in the Biotechnology industry is in the same range as INVA (55) in the Pharmaceuticals Other industry. This means that ATRA’s stock grew similarly to INVA’s over the last 12 months.

INVA's P/E Growth Rating (96) in the Pharmaceuticals Other industry is in the same range as ATRA (97) in the Biotechnology industry. This means that INVA’s stock grew similarly to ATRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRAINVA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
64%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
55%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
58%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
63%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 7 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
54%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ATRA: $9.43 vs. INVA: $21.06)
Brand notoriety: ATRA and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 48% vs. INVA: 60%
Market capitalization -- ATRA: $94.66M vs. INVA: $1.52B
ATRA [@Biotechnology] is valued at $94.66M. INVA’s [@Biotechnology] market capitalization is $1.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 1 FA rating(s) are green while INVA’s FA Score has 1 green FA rating(s).

  • ATRA’s FA Score: 1 green, 4 red.
  • INVA’s FA Score: 1 green, 4 red.
According to our system of comparison, ATRA is a better buy in the long-term than INVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 6 TA indicator(s) are bullish while INVA’s TA Score has 7 bullish TA indicator(s).

  • ATRA’s TA Score: 6 bullish, 3 bearish.
  • INVA’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, INVA is a better buy in the short-term than ATRA.

Price Growth

ATRA (@Biotechnology) experienced а -2.28% price change this week, while INVA (@Biotechnology) price change was +0.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.

Reported Earning Dates

ATRA is expected to report earnings on Nov 11, 2026.

INVA is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ATRA
Daily Signal:
Gain/Loss:
INVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with PHAT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then PHAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+0.86%
PHAT - ATRA
36%
Loosely correlated
-0.28%
LXEO - ATRA
33%
Loosely correlated
-3.67%
INVA - ATRA
33%
Poorly correlated
+0.72%
AUTL - ATRA
31%
Poorly correlated
-2.47%
MOLN - ATRA
31%
Poorly correlated
+3.31%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TFX136.586.18
+4.74%
Teleflex
UPS101.521.95
+1.96%
United Parcel Service
OPK1.630.03
+1.87%
OPKO Health
STG2.37N/A
N/A
Sunlands Technology Group
ABEO4.47-0.04
-0.89%
Abeona Therapeutics